Metcela: Metcela Closes $14M Series C Financing

Metcela, a Kanagawa, Japan-based clinical-stage biotechnology company developing first-in-class autologous cell therapies targeting serious cardiovascular diseases, raised $14M in Series C funding. The round was led by CYBERDYNE Inc. and CEJ Fund, with participation from Japan Lifeline Co., Ltd., Sony Innovation Fund and Reazon Holdings, Inc. The company intends to use the funds to prepare [...]The post Metcela Closes $14M Series C Financing appeared first on FinSMEs.